Verkazia for Patients & Caregivers

The first and only medicine of its kind studied in children with vernal keratoconjunctivitis (VKC)

Verkazia for Patients & Caregivers

The first and only medicine of its kind studied in children with vernal keratoconjunctivitis (VKC)

Verkazia® is a well tolerated, effective solution that helps break the cycle of VKC. It is FDA-approved to treat VKC in children and adults.

Verkazia is not a steroid and can be used without other medications

Learn how Verkazia works

background
background
1200ms
Verkazia helps your kid get back to being a kid

Verkazia® is a well tolerated, effective solution that helps break the cycle of VKC. It is FDA-approved to treat VKC in children and adults.

Verkazia is not a steroid and can be used without other medications

Learn how Verkazia works

Verkazia for VKC: Less irritation, more exploration

Verkazia helps break the cycle of VKC by working with the immune system

  • Verkazia is the only cyclosporine approved for VKC

    Verkazia is an immunomodulator called cyclosporine. It helps stop the activity in the immune system that causes VKC symptoms.

  • Verkazia is safe and effective in children

    Verkazia uses a unique formulation to make sure the eye gets enough cyclosporine to effectively treat VKC.

  • Sticking with Verkazia treatment helps ensure the maximum benefit

    Verkazia every day, 4 times per day, keeps VKC at bay. Your doctor will help decide how long you or your child should take Verkazia.

Verkazia was tested in children and proven effective

Verkazia was studied in more than 100 children in a 12-month-long clinical trial

Verkazia helped improve symptoms like light sensitivity, itching, tearing, and mucous discharge within the first month of using Verkazia

chart
chart

Verkazia helped soothe the inflammation that can cause damage to the clear part of the eye called the cornea

image
chart
Verkazia reduces symptoms within a month
background
background
1200ms

Verkazia has been studied in children in a 12 month trial

Verkazia has a manageable side effect profile. Most side effects occur when the eye drop is given, and go away quickly.

The most common side effects are pain (12%), itching (8%), and discomfort with the drop (6%).

background

VKC is a rare eye disease that can cause unpredictable symptoms year-round

Fast facts about VKC

  • ~49k
    Cases

    VKC is rare. In 2017, there were about 49,000 cases of VKC diagnosed in the United States.

  • Many symptoms

    VKC has many symptoms. These include sensitivity to light, itching, tearing, or discharge from the eye. It may also cause dots on the white of the eye or bumps underneath the eyelid.

  • Not contagious

    VKC is different from pink eye (conjunctivitis). VKC is often mistaken for pink eye because it has many of the same symptoms such as redness, itching, and mucous discharge. Unlike some forms of pink eye, VKC is never contagious.

  • <10 YEARS

    VKC usually begins before children are 10 years old, and often goes away during adolescence. It can continue into adulthood in rare cases.

  • 50%

    VKC has many causes. Only about 50% of people with VKC have an allergy that triggers symptoms. Others have no clear cause and may experience symptoms outside of the allergy season.

Vernal keratoconjunctivitis is not pink eye

For many people, there is no clear cause for VKC symptoms